Today, we welcome Sandra Milligan, M.D., J.D., to Spyre’s Board of Directors! Dr. Milligan has led a remarkable career with her deep understanding of clinical development and regulatory paths, including in IBD. We are confident Dr. Milligan’s expertise and commitment to patients will help us drive forward our portfolio. Please join us in welcoming Dr. Milligan to the Board! Read the full news here: https://bit.ly/4dJjP8M #IBD #BioTech
Congrats Spyre and Sandy - what a great partnership!
Mazel Tov team Spyre and Sandy!
Congrats Sandy and Spyre!
Wonderful news for Spyre- congrats, Sandy!
congrats Sandy!
Propietario en LHH
2momore information in x please